Chemical & Materials Technologies
Group at a Glance
- 13 members
- 11 members have doctorate degrees
- Members' backgrounds include: Organic and Inorganic Chemistry, Chemical Engineering, Material Science, Bioengineering, and Chemical Biology
What Matters to Our Clients
Breadth of Expertise
Our CMT Group has a rare combination of technical depth and breadth of experience, with expertise in virtually all areas of chemistry, chemical engineering, and materials science. All group members have advanced degrees from top universities including MIT, Harvard, and Stanford. Our clients turn to us with confidence for strategic advice on their IP needs knowing we have a complete understanding of their technology and communicate easily with their inventors and scientists.
Superlative Service
Our clients appreciate the fact that our service is a distinctive blend of high quality and sophisticated advice coupled with flexibility, responsiveness, and personal attention. World class scientists, including Nobel Prize winners, as well as industry and technology leaders look to members of our CMT Group for guidance in acquiring and protecting their intellectual property. Our clients cover the spectrum of the chemical and materials technologies from large, established companies and major universities to early stages companies.
The group provides a full range of IP services including: patent preparation and prosecution, opinions and studies related to infringement and patentability, licensing, IP due diligence, interferences, oppositions, litigation, trademarks, and strategic counseling. In order to provide our clients with support on IP issues internationally, we also maintain close working relationships with associates around the world.
Creative Approach
Our members have the drive to look beyond the obvious. They bring novel approaches to protecting our clients’ products and services. We also stay on top of industry developments and take the time to understand our client’s business goals. As a result, our strategies offer the comprehensive protection that gives our clients a competitive advantage.
Areas of Expertise
Examples of our group's areas of expertise include:
- Biochemical engineering
- Biomedical engineering
- Chemical process engineering
- Petrochemical engineering
- Purification & separation technologies
- Unit operation design & chemical reactors
- Analytical chemistry
- Catalysis
- Combinatorial chemistry
- Food product testing
- Imaging agents
- Inorganic chemistry
- Organic chemistry
- Organometallics
- Physical chemistry
- Polymer chemistry
- Sensors
- Batteries
- Fuel cells
- Supercapacitors
- Ceramics
- Coatings & thin films
- Displays
- Materials processing
- MEMS
- Metallurgy
- Microfabrication
- Microfluidics
- Polymers & polymer processing
- Semiconductor materials & processing
- Solid state lighting
- Textiles
- Clinical diagnostics
- Drug screening analysis methods
- Medical imaging
- Tissue engineering
- Braemar Energy Ventures
- C.R. Bard, Inc.
- Cayuga Venture Fund
- CellTech Power
- Dana Farber Cancer Institute
- Davol, Inc.
- Harvard University & Medical School
- Intersouth Partners
- Luminus Devices, Inc.
- Massachusetts Institute of Technology
- Nitronex Corporation
- Nufern
- Primet Precision Materials
- Ranier Technology
- Sion Power Corporation
- SynCardia Systems Inc
- Trevi Health Ventures LP
- Trexel, Inc.
- X Café
December 2011 - Neil Ferraro Named 2012 Boston Patent Law Association President
January 3, 2012 - Wolf Greenfield Welcomes 2012 Promoting Seven Lawyers to New Positions
November 2011 - America Invents Act: The Implications of Patent Reform
October 12, 2011 - Wolf Greenfield sponsored MIT Forum event on October 12
September 2011 - America Invents Act – Patent Reform is Finally Here
September 9, 2011 - IP ALERT—Senate Endorses The Long-Awaited Patent Reform
February 25, 2011 - Managing the Pace of Patent Applications
February 17, 2011 - WOLF GREENFIELD SEMINAR: Managing IP Risks: The Importance of Obtaining Freedom to Operate Guidance - presentation now available
January 1, 2011 - Wolf Greenfield filed 2,749 patent applications and 688 trademark applications in 2010.
December 2010 - Wolf Greenfield was ranked #1 in number of patents filed and number of patent attorneys in Mass High Tech’s annual survey
August 22, 2010 - Hunter Baker, Ed Gates and Chelsea Loughran presented at the American Chemical Society’s Fall National Meeting
August 20, 2010 - BBJ survey ranks Wolf Greenfield #1 in patent attorneys, patents filed and patents obtained
July 7, 2010 - A Wolf Greenfield Webinar: Forecasting the Future of Method Patents Post-Bilski — archived replay of webinar now available
June 28, 2010 - CLIENT ALERT— Supreme Court Leaves Door Open to Business Method Patents
June 17, 2010 - WOLF GREENFIELD SEMINAR: Strategically Building and Monetizing a Patent Portfolio - replay now available
October 15, 2009 - CLIENT ALERT — USPTO Rescinds Controversial Rules Restricting Patent Applications
September 24, 2009 - CLIENT ALERT — Federal Circuit Confirms Diagnostic and Therapeutic Methods Can be Patentable Subject Matter
May 14, 2009 - Our clients Cambridge NanoTech and E Ink named winners of SBANE’s New England Innovation Awards, and our client Formulatrix named as finalist
March 25, 2009 - CLIENT ALERT — Federal Circuit Decision on Controversial PTO Rules
February 2009 - Maximizing Intellectual Property Value in Tough Economic Times- Seminar replay now available
WHITE PAPER - Energy, Cleantech, and Intellectual Property: Managing Technology Convergence and Protecting Innovation
November 12, 2008 - Navigating Technology Collaborations and Joint Ventures—Wolf Greenfield seminar
February 7, 2008 - An Entrepreneur's Guide to the Intellectual Property Galaxy
March 21, 2007 - Wolf Greenfield Names Oyer President and Managing Partner - Lawyer/Scientist Takes Reins at Boston Intellectual Property Law Firm
March 2007 - Can a Biological Sequence be Copyrighted?
November 2006 - Accelerated Examination of Patent Applications: Too Good To Be True?
Q&A Booklet - Q&A on Patents
Q&A Booklet - Q&A on Intellectual Property Litigation
Q&A Booklet - Q&A on Licensing and Transactions
